Lymphoma
Poteligeo (Mogamulizumab)

Poteligeo® is indicated for the treatment of adult patients with Mycosis Fungoides (MF) or Sézary Syndrom (SS) who have received at least one prior systemic treatment.
For full details please refer to the PI as approved by the IL MoH.